Cargando…
Interferon-β Pretreatment of Conventional and Plasmacytoid Human Dendritic Cells Enhances Their Activation by Influenza Virus
Influenza virus produces a protein, NS1, that inhibits infected cells from releasing type I interferon (IFN) and blocks maturation of conventional dendritic cells (DCs). As a result, influenza virus is a poor activator of both mouse and human DCs in vitro. However, in vivo a strong immune response t...
Autores principales: | Phipps-Yonas, Hannah, Seto, Jeremy, Sealfon, Stuart C., Moran, Thomas M., Fernandez-Sesma, Ana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568957/ https://www.ncbi.nlm.nih.gov/pubmed/18974865 http://dx.doi.org/10.1371/journal.ppat.1000193 |
Ejemplares similares
-
Production of type I interferons: plasmacytoid dendritic cells and beyond
por: Asselin-Paturel, Carine, et al.
Publicado: (2005) -
The Role of Plasmacytoid Dendritic Cells and Interferon-Alpha in the Immunopathogenesis of Psoriasis
por: Denadai, Rafael
Publicado: (2013) -
Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship
por: Finotti, Giulia, et al.
Publicado: (2017) -
Impaired interferon‐α expression in plasmacytoid dendritic cells in asthma
por: Lin, Ting‐Yu, et al.
Publicado: (2020) -
Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease
por: Zheng, Dong, et al.
Publicado: (2012)